PIL - Dorzolamide 20mg/ml Eye Drops solution: Change history
View Patient Information Leaflet (PIL - Dorzolamide 20mg/ml Eye Drops solution)
Last updated on this site: 20 Feb 2026
Description of update: To update section 4.8 of the SmPC and PIL in line with PRAC recommendation (PSUSA/00003168/202502), to add photophobia as an adverse reaction.
Date of approval: 13/02/2026
PIL sections updated: 4 and 6
Last updated on this site: 20 Feb 2026
Description of update: To update section 4.8 of the SmPC and PIL in line with PRAC recommendation (PSUSA/00003168/202502), to add photophobia as an adverse reaction.
Date of approval: 13/02/2026
PIL sections updated: 4 and 6
-
Changes: (Updated: 20 Feb 2026)
Description of update: To update section 4.8 of the SmPC and PIL in line with PRAC recommendation (PSUSA/00003168/202502), to add photophobia as an adverse reaction.
Date of approval: 13/02/2026
PIL sections updated: 4 and 6
-
Changes: (Updated: 28 Apr 2023)
Variation Description: To update sections 4.2 and 4.8 of the SPC to bring in line with the PRAC recommendations (PRACPSUSA/00003168/202202). Consequently, the leaflet has been updated. Additionally, section 4.6 of the SPC has been updated; the brand name Trusopt has been replaced with dorzolamide and the product description in section 6 of the PIL has been updated in line with section 3 of the SPC.
PIL sections updated – 3, 4 and 6.
-
Changes: (Updated: 06 Dec 2022)
Update to manufacturer information
-
Changes: (Updated: 20 Sep 2022)
Initial upload